GLN-APREMILAST — Canadian drug shortage status
Manufacturer: GLENMARK PHARMACEUTICALS CANADA INC.
1 active report
Shortage reports for GLN-APREMILAST filed with Health Canada's drug shortage register, as tracked by Nexara. Each row is one reported presentation or strength.
| Status | Strength / detail | Estimated resolution | Tier | Last seen | Source |
|---|---|---|---|---|---|
| active | 30MG | 2026-09-04 | healthproductshortages.ca |
Sourcing during a shortage
When a Canadian product is in shortage, Health Canada may permit exceptional importation of a foreign-authorized equivalent, and practitioners may apply through the Special Access Programme. Read how named-patient and foreign-pack supply works in Canada.
Request a quote for GLN-APREMILAST